← Back to Intel
Insider ActivityROIV
Gline Matthew, CEO, Director at Roivant Sciences Ltd., traded $8.4M of ROIV
Updated Jun 11, 2026
Gline Matthew
CEO, Director
Roivant Sciences Ltd. ·
$ROIV
Transaction Details
| Insider | Gline Matthew |
|---|---|
| Title | CEO, Director |
| Company | Roivant Sciences Ltd. |
| Ticker | ROIV |
| Transaction Type | Tax |
| Transaction Date | 2026-03-31 |
| Shares Traded | 304,684 |
| Price Per Share | $27.7 |
| Total Value | $8.4M |
| Filed Date | 2026-04-01 |
| Accession Number | 0001635088-26-000034 |
Ownership Context
| Shares Owned After Transaction | 17,025,890 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001635088-26-000034
Other Insider Trades — ROIV
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Venker Eric | President & Immunovant CEO | traded | $770K | 2026-05-22 |
| Venker Eric | President & Immunovant CEO | sold | $6.1M | 2026-05-22 |
| Pulik Richard | CFO | traded | $615K | 2026-05-20 |
| Venker Eric | President & Immunovant CEO | traded | $1.1M | 2026-05-20 |
| Pulik Richard | CFO | traded | — | 2026-04-20 |
| Venker Eric | President & Immunovant CEO | sold | $5.9M | 2026-04-20 |
| Humes Jennifer | Chief Accounting Officer | traded | — | 2026-04-20 |
| Humes Jennifer | Chief Accounting Officer | traded | — | 2026-04-20 |
| Venker Eric | President & Immunovant CEO | traded | $770K | 2026-04-20 |
| Pulik Richard | CFO | traded | — | 2026-04-20 |
Other Trades by Gline Matthew
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | sold | $8.4M | 2026-04-16 |
| ROIV | Roivant Sciences Ltd. | traded | — | 2026-03-30 |
| ROIV | Roivant Sciences Ltd. | traded | $1.4M | 2026-03-30 |
| ROIV | Roivant Sciences Ltd. | traded | $25.0M | 2026-03-30 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ROIV — Roivant Sciences Ltd. →
Track ROIV insider activity in real time on The Wire →
Get alerts when Gline Matthew files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 11, 2026 at 07:22 UTC